Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nadia Howlader

Showing results (1-10 of 49) with videos related to

Pageof 5
Sort By:
Statistics in Medicine|December 7, 2016
Imputing estrogen receptor (ER) status in a population-based cancer registry: a sensitivity analysisRebecca Andridge, Anne-Michelle Noone, Nadia Howlader
Journal of the National Cancer Institute|August 1, 2025
Stat Bite: Convergence of long-term trends in cervix uteri cancer incidence among Black and White women from 1975 to 2021Nadia Howlader, Mark E Sellers, Kathleen A Cronin
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 2, 2011
Breast cancer incidence rates in U.S. women are no longer decliningCarol DeSantis, Nadia Howlader, Kathleen A Cronin, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 22, 2019
Differences in Cancer Survival with Relative versus Cause-Specific Approaches: An Update Using More Accurate Life TablesGonçalo Forjaz de Lacerda, Nadia Howlader, Angela B Mariotto
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 22, 2004
Chemotherapy use, outcomes, and costs for older persons with advanced non-small-cell lung cancer: evidence from surveillance, epidemiology and end results-MedicareScott D Ramsey, Nadia Howlader, Ruth D Etzioni, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 30, 2018
Differences in Breast Cancer Survival by Molecular Subtypes in the United StatesNadia Howlader, Kathleen A Cronin, Allison W Kurian, et al.
Journal of the National Cancer Institute. Monographs|November 24, 2014
Providing clinicians and patients with actual prognosis: cancer in the context of competing causes of deathNadia Howlader, Angela B Mariotto, Steven Woloshin, et al.
American Journal of Epidemiology|July 31, 2012
Use of imputed population-based cancer registry data as a method of accounting for missing information: application to estrogen receptor status for breast cancerNadia Howlader, Anne-Michelle Noone, Mandi Yu, et al.
The Oncologist|January 18, 2007
Cancer statistics, trends, and multiple primary cancer analyses from the Surveillance, Epidemiology, and End Results (SEER) ProgramMatthew J Hayat, Nadia Howlader, Marsha E Reichman, et al.
Journal of the National Cancer Institute|March 26, 2009
The impact of underreported Veterans Affairs data on national cancer statistics: analysis using population-based SEER registriesNadia Howlader, Lynn A Ries, David G Stinchcomb, et al.
Pageof 5

Showing results (1-10 of 49) with videos related to

Sort By:
Pageof 5
Statistics in Medicine|December 7, 2016
Imputing estrogen receptor (ER) status in a population-based cancer registry: a sensitivity analysisRebecca Andridge, Anne-Michelle Noone, Nadia Howlader
Journal of the National Cancer Institute|August 1, 2025
Stat Bite: Convergence of long-term trends in cervix uteri cancer incidence among Black and White women from 1975 to 2021Nadia Howlader, Mark E Sellers, Kathleen A Cronin
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 2, 2011
Breast cancer incidence rates in U.S. women are no longer decliningCarol DeSantis, Nadia Howlader, Kathleen A Cronin, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 22, 2019
Differences in Cancer Survival with Relative versus Cause-Specific Approaches: An Update Using More Accurate Life TablesGonçalo Forjaz de Lacerda, Nadia Howlader, Angela B Mariotto
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 22, 2004
Chemotherapy use, outcomes, and costs for older persons with advanced non-small-cell lung cancer: evidence from surveillance, epidemiology and end results-MedicareScott D Ramsey, Nadia Howlader, Ruth D Etzioni, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 30, 2018
Differences in Breast Cancer Survival by Molecular Subtypes in the United StatesNadia Howlader, Kathleen A Cronin, Allison W Kurian, et al.
Journal of the National Cancer Institute. Monographs|November 24, 2014
Providing clinicians and patients with actual prognosis: cancer in the context of competing causes of deathNadia Howlader, Angela B Mariotto, Steven Woloshin, et al.
American Journal of Epidemiology|July 31, 2012
Use of imputed population-based cancer registry data as a method of accounting for missing information: application to estrogen receptor status for breast cancerNadia Howlader, Anne-Michelle Noone, Mandi Yu, et al.
The Oncologist|January 18, 2007
Cancer statistics, trends, and multiple primary cancer analyses from the Surveillance, Epidemiology, and End Results (SEER) ProgramMatthew J Hayat, Nadia Howlader, Marsha E Reichman, et al.
Journal of the National Cancer Institute|March 26, 2009
The impact of underreported Veterans Affairs data on national cancer statistics: analysis using population-based SEER registriesNadia Howlader, Lynn A Ries, David G Stinchcomb, et al.
Pageof 5